Visa shares hit 52-week high after Trump buys millions in stock

scanx
Reviewed by
Ritika DScanX News Team
Key Highlights
  • Visa shares rose 2.53% to $380.45, hitting a new 52-week high
  • President Donald Trump's accounts bought millions in Visa stock in June 2026
  • The purchase was part of $78.1 million to $263.1 million in total trades
  • Shares trade above all major moving averages, including a 14.5% premium to the 200-day average
  • A golden cross formed in July, supporting the longer-term uptrend
powered bylight_fuzz_icon
49141426

*this image is generated using AI for illustrative purposes only.

Visa Inc (NYSE: V) shares rose to a new 52-week high on Monday following financial disclosures that President Donald Trump's investment accounts purchased millions of dollars worth of the payment processor's stock during June 2026.

The purchase was part of a broader portfolio reshuffle. A financial disclosure released in August detailed more than 1,000 separate securities trades executed by Trump's accounts in June, totaling between $78.1 million and $263.1 million.

Portfolio Moves

According to CNBC, Trump's accounts trimmed holdings in Meta and Motorola by between $1 million and $5 million each on June 18. The proceeds were deployed into Visa, Berkshire Hathaway, Cintas, and Mastercard on the same day.

Such trades often draw market attention as they signal how one of the world's most closely watched public figures is positioning capital, though analysts note these moves are not standalone reasons to buy or sell.

Technical Outlook

Visa's technical indicators support the bullish sentiment. Shares traded above all major moving averages at the time of publication:

Moving Average Premium over Price
20-day average 3.8%
50-day average 7.4%
100-day average 13.1%
200-day average 14.5%

The 20-day average remains above the 50-day average, confirming near-term buyer dominance. Momentum indicators also show strength, with the MACD line above its signal line and a positive histogram.

A golden cross formed in July when the 50-day average crossed above the 200-day average, reinforcing the longer-term constructive backdrop for trend-following investors.

Price Action

Visa shares were up 2.53% to $380.45 at the time of publication, surpassing the prior 52-week high of $373.97.

Traders are monitoring $348.50 as a key support level. This zone aligns closely with the rising 50-day average and has previously seen buying interest. A failure to hold the breakout above the previous high could see the stock retreat toward these short-term averages.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

Will the correlation between Trump's portfolio shifts and Visa's stock performance persist, or will the market discount these trades as non-informative signals?

How might Visa's recent breakout above $380 impact its valuation multiples relative to competitors like Mastercard in the near term?

If Visa fails to hold the $348.50 support level after a potential pullback, what does that imply for the validity of the July golden cross technical setup?

like15
dislike

Visa shares rise 1.3% to $370 on broad market strength

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights
  • Visa shares rose 1.3% to $370.48 on Friday amid broad market bullishness
  • Company agreed to acquire fraud prevention firm BioCatch for $2.4 billion in cash
  • Stock trades above 20-day and 50-day SMAs but shows cooling momentum via MACD
  • Analysts estimate EPS of $3.43 and revenue of $12.09 billion for October 2026 report
powered bylight_fuzz_icon
48870094

*this image is generated using AI for illustrative purposes only.

Visa Inc. (NYSE: V) shares rose 1.3% to $370.48 on Friday, supported by firm risk appetite and broader market bullishness. The payment processor’s stock held near recent highs, tracking the S&P 500’s 0.2% gain.

The early strength lacked a single specific headline driver, instead reflecting a supportive tone for large-cap, liquid names. Visa is currently pressing into a technical zone where traders monitor for either a breakout or a quick fade.

Acquisition of BioCatch

This month, Visa disclosed an agreement to acquire fraud prevention company BioCatch for $2.4 billion in cash. The deal strengthens Visa’s artificial intelligence-powered cybersecurity and fraud detection capabilities.

BioCatch’s behavioral intelligence technology will integrate with Visa’s existing security, fraud, and risk management offerings. The company stated the acquisition will help financial institutions detect scams, account takeovers, money mule activity, and application fraud before payments are processed.

Technical Levels and Momentum

Visa trades 0.7% above its 20-day simple moving average (SMA) of $364.51 and 4.3% above its 50-day SMA of $351.79. This positioning keeps the intermediate trend pointed up, suggesting dips have been bought.

The longer-term backdrop remains constructive, with the 50-day SMA above the 200-day SMA, a golden cross that occurred in July. However, momentum indicators show cooling upside pressure. The Moving Average Convergence Divergence (MACD) is below its signal line with a negative histogram, indicating the trend is up but losing steam unless buyers reassert control.

Metric Level Significance
Key Resistance $374.00 Aligns with 52-week high of $373.97
Key Support $348.50 Near 50-day SMA/EMA area ($351.79/$353.12)
Current Price $370.48 Up 1.30% on Friday

Earnings Preview and Analyst Outlook

The next major catalyst for the stock is the estimated earnings report on October 27, 2026. Analysts expect earnings per share (EPS) of $3.43, up from $2.98 year-over-year. Revenue is estimated at $12.09 billion, compared to $10.72 billion in the prior year.

The stock carries a Buy rating with an average price forecast of $417.63. Recent analyst actions include:

  • Truist Securities: Buy rating, raised target to $406.00 on Aug. 5
  • Cantor Fitzgerald: Overweight rating, raised target to $445.00 on Aug. 3
  • Wells Fargo: Overweight rating, raised target to $432.00 on July 30

ETF Exposure

Visa holds significant weight in several key exchange-traded funds, meaning inflows or outflows from these funds could force automatic buying or selling of the stock.

  • State Street Financial Select Sector SPDR ETF (NYSE: XLF): 7.47% weight
  • Corgi Digital Banking & Fintech Infrastructure ETF (NASDAQ: KYC): 9.38% weight
  • Akre Focus ETF (NYSE: AKRE): 7.18% weight
Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How might the integration of BioCatch's behavioral intelligence impact Visa's fraud-related revenue streams and customer acquisition costs in the next 12-18 months?

Given the cooling momentum indicators like the negative MACD histogram, what specific volume or price action would confirm a breakout above the $374 resistance versus a pullback to the $350 support zone?

To what extent could potential regulatory scrutiny on large-scale fintech acquisitions delay or alter the strategic benefits Visa expects from the $2.4 billion BioCatch deal?

like17
dislike

More News on Visa